{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:10:35Z","timestamp":1789593035116,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["HT94252430004"],"award-info":[{"award-number":["HT94252430004"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["W81XWH-18-2-0040"],"award-info":[{"award-number":["W81XWH-18-2-0040"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201100016C"],"award-info":[{"award-number":["HHSN272201100016C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN26120150003I"],"award-info":[{"award-number":["HHSN26120150003I"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","award":["5P30 AI064518"],"award-info":[{"award-number":["5P30 AI064518"]}],"id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.103022","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:42:41Z","timestamp":1788360161000},"page":"103022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preferential engagement of the anti-inflammatory ATP\/adenosine axis by HIV vaccine candidate with V1-deleted envelope in male rhesus macaques"],"prefix":"10.1016","volume":"7","author":[{"given":"Isabela","family":"Silva de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-8943","authenticated-orcid":false,"given":"Mohammad Arif","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Goldfarbmuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Schifanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarkis","family":"Sarkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kombo F.","family":"N\u2019guessan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gutowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Stamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin N.","family":"Doster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel K.","family":"Woode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaTonya D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampa","family":"Santra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Paquin-Proulx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Maldarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-6589","authenticated-orcid":false,"given":"Genoveffa","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103022_bib1","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(12)70088-9","article-title":"Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B\/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144","volume":"12","author":"Robb","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2026.103022_bib3","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/JVI.00718-12","article-title":"Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion","volume":"87","author":"Alam","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103022_bib4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075665","article-title":"Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial","volume":"8","author":"Gottardo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.103022_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108446","article-title":"Cryptic determinant of alpha4beta7 binding in the V2 loop of HIV-1 gp120","volume":"9","author":"Tassaneetrithep","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.103022_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aam7341","article-title":"Virion incorporation of integrin alpha4beta7 facilitates HIV-1 infection and intestinal homing","volume":"2","author":"Guzzo","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007278","article-title":"Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to alpha4beta7","volume":"14","author":"Lertjuthaporn","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.103022_bib9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib10","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1089\/aid.2012.0103","article-title":"The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120","volume":"28","author":"Karasavvas","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.xcrm.2026.103022_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"Rolland","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103022_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ni1566","article-title":"HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells","volume":"9","author":"Arthos","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib13","doi-asserted-by":"crossref","first-page":"32566","DOI":"10.1073\/pnas.2011501117","article-title":"The V2 loop of HIV gp120 delivers costimulatory signals to CD4(+) T cells through Integrin alpha4beta7 and promotes cellular activation and infection","volume":"117","author":"Goes","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103022_bib14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm.4105","article-title":"Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition","volume":"22","author":"Vaccari","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41591-018-0025-7","article-title":"HIV vaccine candidate activation of hypoxia and the inflammasome in CD14(+) monocytes is associated with a decreased risk of SIVmac251 acquisition","volume":"24","author":"Vaccari","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41467-023-36109-8","article-title":"HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC","volume":"14","author":"Bissa","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103022_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008377","article-title":"Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition","volume":"16","author":"Gorini","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.103022_bib18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41564-023-01353-7","article-title":"Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques","volume":"8","author":"Rahman","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2026.103022_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102047","article-title":"Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates","volume":"24","author":"Silva de Castro","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2026.103022_bib20","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1038\/s41467-024-53359-2","article-title":"Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response","volume":"15","author":"Rahman","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103022_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1441793","article-title":"Vaccine induced mucosal and systemic memory NK\/ILCs elicit decreased risk of SIV\/SHIV acquisition","volume":"15","author":"Rahman","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011407","article-title":"Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein","volume":"19","author":"Grunst","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.103022_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01864-22","article-title":"Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil\/Helical or beta-Sheet Conformations on Time of SIV(mac251) Acquisition","volume":"97","author":"Stamos","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103022_bib24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3389\/fimmu.2019.01072","article-title":"Myeloid Cell Crosstalk Regulates the Efficacy of the DNA\/ALVAC\/gp120 HIV Vaccine Candidate","volume":"10","author":"Vaccari","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib25","article-title":"Sustained mucosal delivery of SAMT-247 via an intravaginal ring reduces the risk of SIV(mac251) acquisition in vaccinated macaques","volume":"7","author":"Rahman","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15711","article-title":"Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge","volume":"8","author":"Bradley","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103022_bib27","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1128\/JVI.00196-11","article-title":"Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic","volume":"85","author":"Euler","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103022_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103022_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12883-6","article-title":"Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity","volume":"7","author":"Mayr","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103022_bib30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","article-title":"Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults","volume":"384","author":"Gray","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004360","article-title":"Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1\/2a randomized trial","volume":"21","author":"Moodie","year":"2024","journal-title":"PLoS Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib32","doi-asserted-by":"crossref","first-page":"e01843-17","DOI":"10.1128\/JVI.01843-17","article-title":"HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees","volume":"92","author":"Yates","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103022_bib33","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S2352-3018(18)30071-7","article-title":"Subtype C ALVAC-HIV and bivalent subtype C gp120\/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1\/2 trial","volume":"5","author":"Bekker","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.xcrm.2026.103022_bib34","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4049\/jimmunol.169.3.1277","article-title":"Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response","volume":"169","author":"Hauser","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1023\/A:1020558317162","article-title":"Dendritic cells: a link between innate and adaptive immunity","volume":"19","author":"Palucka","year":"1999","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI9094","article-title":"Umbilical cord blood: an expandable resource","volume":"105","author":"Moore","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103022_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41423-019-0218-0","article-title":"Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10)","volume":"17","author":"Comi","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib38","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.4049\/jimmunol.1900572","article-title":"Differential Effect of Mucosal NKp44(+) Innate Lymphoid Cells and Deltagamma Cells on Simian Immunodeficiency Virus Infection Outcome in Rhesus Macaques","volume":"203","author":"Rahman","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib39","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1521-4141(200209)32:9<2680::AID-IMMU2680>3.0.CO;2-6","article-title":"ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells","volume":"32","author":"Witsch","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20020632","article-title":"Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10","volume":"197","author":"L\u00f6hning","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.103022_bib41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.humimm.2007.06.004","article-title":"Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes","volume":"68","author":"Lingnau","year":"2007","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib42","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","article-title":"Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution","volume":"49","author":"Proto","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103022_bib43","article-title":"T(FH) Cells Induced by Vaccination and Following SIV Challenge Support Env-Specific Humoral Immunity in the Rectal-Genital Tract and Circulation of Female Rhesus Macaques","volume":"11","author":"Helmold Hait","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep26494","article-title":"ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination","volume":"6","author":"Bentebibel","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103022_bib46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103022_bib47","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103022_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040309","article-title":"The CD39\/CD73\/Adenosine and NAD\/CD38\/CD203a\/CD73 Axis in Cutaneous T-Cell Lymphomas","volume":"14","author":"Lin","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.103022_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.103022_bib49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/infdis\/jiac260","article-title":"Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk","volume":"226","author":"Moodie","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.xcrm.2026.103022_bib50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/cdd.2016.159","article-title":"CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages","volume":"24","author":"Murphy","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.103022_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cells13050381","article-title":"Adenosine in Intestinal Epithelial Barrier Function","volume":"13","author":"Stepanova","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.103022_bib52","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.celrep.2013.05.022","article-title":"Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity","volume":"3","author":"Schena","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103022_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2016.00121","article-title":"Circulating Human Neonatal Naive B Cells are Deficient in CD73 Impairing Purine Salvage","volume":"7","author":"Pettengill","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191973","article-title":"CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination","volume":"13","author":"Allard","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.103022_bib55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1073\/pnas.1407466112","article-title":"Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag\/Tat-vaccinated rhesus macaques","volume":"112","author":"Carnathan","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103022_bib56","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1073\/pnas.1400446111","article-title":"Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103022_bib57","doi-asserted-by":"crossref","first-page":"19940","DOI":"10.1073\/pnas.0907898106","article-title":"Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1","volume":"106","author":"Benlahrech","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103022_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.166292","article-title":"IL-15 enhances HIV-1 infection by promoting survival and proliferation of CCR5+CD4+ T cells","volume":"8","author":"Li","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.103022_bib59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.180.1.350","article-title":"IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses","volume":"180","author":"Mueller","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib60","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/aid.2014.0034","article-title":"Sequence-conserved and antibody-accessible sites in the V1V2 domain of HIV-1 gp120 envelope protein","volume":"30","author":"Shmelkov","year":"2014","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.xcrm.2026.103022_bib61","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1126\/science.1093137","article-title":"Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission","volume":"303","author":"Derdeyn","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103022_bib62","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1128\/JVI.02308-13","article-title":"Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1\/V2 domains","volume":"88","author":"Cavrois","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103022_bib63","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1038\/s41467-018-06794-x","article-title":"Common helical V1V2 conformations of HIV-1 Envelope expose the alpha4beta7 binding site on intact virions","volume":"9","author":"Wibmer","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103022_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1139402","article-title":"Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV(mac251) acquisition in macaques","volume":"14","author":"Rahman","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib65","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1038\/s41467-025-63610-z","article-title":"HIV vaccine candidate DeltaV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques","volume":"16","author":"Bissa","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103022_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011860","article-title":"The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin \u237a4beta7","volume":"19","author":"Van Ryk","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.103022_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011819","article-title":"Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge","volume":"20","author":"Grunst","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.103022_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/08820139709048912","article-title":"NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics","volume":"26","author":"Romano","year":"1997","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.xcrm.2026.103022_bib69","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1073\/pnas.82.21.7458","article-title":"Blockade of beta 1- but not of beta 2-adrenergic receptors replicates propranolol's suppression of the cerebral spread of an engram in mice","volume":"82","author":"Flexner","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103022_bib70","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103022_bib71","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1128\/JVI.01163-16","article-title":"Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA\/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques","volume":"90","author":"Iyer","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103022_bib72","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"Montefiori","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.103022_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","article-title":"Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1","volume":"409","author":"Sarzotti-Kelsoe","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.xcrm.2026.103022_bib74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2016.03.002","article-title":"A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies","volume":"433","author":"Orlandi","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.xcrm.2026.103022_bib75","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.celrep.2018.11.020","article-title":"CMV Primes Functional Alternative Signaling in Adaptive Deltag NK Cells but Is Subverted by Lentivirus Infection in Rhesus Macaques","volume":"25","author":"Shah","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103022_bib76","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.immuni.2014.09.005","article-title":"Development, differentiation, and diversity of innate lymphoid cells","volume":"41","author":"Diefenbach","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103022_bib77","article-title":"The role of group 3 innate lymphoid cell in intestinal disease","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib78","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib79","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/mi.2008.60","article-title":"CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIV(mac251) infection","volume":"1","author":"Vaccari","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib80","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.4049\/jimmunol.180.8.5439","article-title":"Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection","volume":"180","author":"Cecchinato","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103022_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:46:15Z","timestamp":1789591575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004398"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103022","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferential engagement of the anti-inflammatory ATP\/adenosine axis by HIV vaccine candidate with V1-deleted envelope in male rhesus macaques","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103022"}}